您的位置: 首页 > 农业专利 > 详情页

ENGINEERED ENDOTHELIAL CELLS EXPRESSING AN ETS TRANSCRIPTION FACTOR
专利权人:
ANGIOCRINE BIOSCIENCE; INC.
发明人:
Daniel Joseph Nolan,Paul William Finnegan,Michael Daniel Ginsberg,Claude Geoffrey Davis
申请号:
US15746397
公开号:
US20180195040A1
申请日:
2016.07.19
申请国别(地区):
US
年份:
2018
代理人:
摘要:
In some aspects the present invention relates to engineered endothelial cells, such as E40RF1+ ETV2+ engineered endothelial cells. In other aspects the present invention relates to methods of making such engineered endothelial cells, and methods of using such engineered endothelial cells, for example in co-culture applications.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充